#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    CDKL5 deficiency disorder Retinal artery occlusion Systemic sclerosis pulmonary Necrotising enterocolitis neonatal Juvenile psoriatic arthritis Focal segmental glomerulosclerosis Gastrointestinal disorder Metastases to central nervous system Vulval cancer Adenocarcinoma gastric Hyperphagia Oesophageal squamous cell carcinoma stage II Congenital disorder of glycosylation Philadelphia chromosome positive Ocular myasthenia More trials…

    Learn about Rare Diseases

    Retinoblastoma Small intestine leiomyosarcoma – Life with Disease Paroxysmal nocturnal haemoglobinuria – Trials in Disease Metachromatic leukodystrophy – Basic Information Ewing’s sarcoma – Life with Disease Glomerulonephritis membranous – Treatment Sarcoidosis – Diagnostics Hereditary ataxia – Life with Disease Primary hyperoxaluria – Basic Information Alternating hemiplegia of childhood – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Panobinostat Topotecan S095035 Lactulose Ademetionine M-(18F)-Fluorobenzylguanidine Ambrisentan Prednisolone Sodium Phosphate E2814 IHMA-2121771-1 Afatinib Vixarelimab Zagociguat ALN-4324 Ltx-315 ATOVAQUONE Elezanumab Cilastatin Sodium ARGININE GLUTAMATE Fluvastatin More therapies…

    Learn about Your Condition

    Inflammation Arteriosclerosis Fontan procedure Medulloblastoma recurrent Choroidal dystrophy Pterygium Migraine with aura Noninfective chorioretinitis Nodular melanoma Malignant melanoma stage III Renal failure Amyotrophic lateral sclerosis Dermatitis Spinal cord injury cervical Adenovirus infection More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on Optimizing Ceftazidime-Avibactam Dosing for Critically Ill Patients Undergoing Continuous Renal Replacement Therapy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Critical illness
    Investigated Drugs:
    • Avibactam
    • Ceftazidime
    Belgium Spain Sweden

  • Study on the Effectiveness of Neoadjuvant Chemotherapy with Oxaliplatin and Capecitabine for Patients with Locally Advanced Colon Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Colon cancer
    Investigated Drugs:
    • Capecitabine
    • Oxaliplatin
    Spain

  • Study of nivolumab and ipilimumab combination therapy as an alternative to surgery and radiation in patients with skin squamous cell carcinoma

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Ipilimumab
    • Nivolumab
    The Netherlands

  • Study on Vitamin D and Oral Iron for Patients with Chronic Heart Failure and Iron Deficiency

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cardiac failure congestive
    • Cardiac failure chronic
    • Iron deficiency
    Investigated Drugs:
    • Ferric Carboxymaltose
    • Colecalciferol
    Italy

  • Study on the Effectiveness and Safety of Vedolizumab and Upadacitinib in Adults with Moderate to Severe Crohn’s Disease

    Recruiting

    3 1 1
    Investigated Drugs:
    • Vedolizumab
    • Upadacitinib
    Austria Belgium Croatia Czechia Denmark France +12

  • Study on the Effects of Sacubitril/Valsartan and Ramipril on Heart Function in Patients with Ischemic Heart Failure with Mid-Range Ejection Fraction

    Recruiting

    3 1 1
    Investigated Drugs:
    • Hydrochlorothiazide
    • Ramipril
    • Sacubitril
    Poland
Previous Page
1 … 288 289 290 291 292 … 1,649
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!